Heterogeneous cancer‐associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer-Reference-Cited by-同舟云学术

Heterogeneous cancer‐associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer

Published:2022-07-05 Issue:1 Volume:167 Page:1-14
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Zhang Zhilin¹^ORCID,Zhang Huan¹,Shi Lin¹,Wang Daorong²,Tang Dong²

Affiliation:

1. Clinical Medical College Yangzhou University Yangzhou China

2. Department of General Surgery, Institute of General Surgery, Clinical Medical College Yangzhou University, Northern Jiangsu People's Hospital Yangzhou China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13496

Reference102 articles.

1. Cancer immunotherapy: harnessing the immune system to battle cancer

2. Immunotherapy and Prevention of Pancreatic Cancer

3. Hallmarks of Cancer: New Dimensions

4. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

5. Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IFIT1 + neutrophil is a causative factor of immunosuppressive features of poorly cohesive carcinoma (PCC);Journal of Translational Medicine;2024-06-19

2. Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy;Immunology;2024-04-15

3. Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma;Biomolecules & Therapeutics;2024-04-10

4. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies;Frontiers in Oncology;2024-03-25

5. Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies;Cellular Oncology;2023-09-18